Product Images Iclusig

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Iclusig NDC 63020-534 by Takeda Pharmaceuticals America, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - iclusig 01

Chemical Structure - iclusig 01

PRINCIPAL DISPLAY PANEL - 15 mg Tablet Bottle Label - iclusig 02

PRINCIPAL DISPLAY PANEL - 15 mg Tablet Bottle Label - iclusig 02

This is a medication with the name Iclusig, which comes in the form of tablets with 15mg of ponatinib. The tablet container has a label indicating the drug's name, dosage, storage recommendations, and prescription only usage. The drug is distributed by Takeda Pharmaceuticals in the USA and made in Canada. Anyone using the medications should keep it away from children, and dosage instructions should be read from accompanying documents.*

PRINCIPAL DISPLAY PANEL - 45 mg Tablet Bottle Label - iclusig 03

PRINCIPAL DISPLAY PANEL - 45 mg Tablet Bottle Label - iclusig 03

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - iclusig 04

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - iclusig 04

FPO is a pharmaceutical product with NDC 63020-533-30 comprising of Ponatinib tablets that contains 30 mg Ponatinib equivalent to 32.05 mg Ponatinib HCI. It is recommended to store this product at 20° to 25°C and keep away from children. Dosage and usage should be in accordance with the prescribed medication guide, and the product is distributed by Takeda Pharmaceuticals America, Inc. It contains 30 tablets for Rx only.*

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label - iclusig 05

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label - iclusig 05

Store the IcLusic tablets containing 10mg ponatinib at a temperature between 20° to 25°C (68° to 77°F). The temperature can be slightly increased to 15° to 30°C (59° to 86°F) for excursions. The recommended dosage and use are available in the accompanying prescribing information. It is advisable to keep the tablets away from children. The product NDC code is 63020-536-30. The tablets contain 10.68 mg ponatinib HCI. A medication guide should be dispensed along with the 30 tablets. Rx use only.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.